GlassScriptPhysician profile
Steven A Vela
NPI 1831134816
$9,424.51
in general payments reported to CMS, 2019-2025
25 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $421 · 2021: $142 · 2022: $46.14 · 2023: $67.71 · 2024: $7,956 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,000 · Food and Beverage: $1,126 · Travel and Lodging: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,000.00 |
| Food and Beverage | $1,125.95 |
| Travel and Lodging | $306.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,698.06 | 2019-2025 | |
| Integra Lifesciences Corporation | $106.47 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Boston Scientific Corporation | $67.71 | 2023 | Exalt Model D |
| Stryker Corporation | $60.19 | 2019-2025 | Molli |
| Conmed Corporation | $45.45 | 2019 | |
| Lemaitre Vascular, INC. | $45.15 | 2019 | |
| Hologic Sales and Service, LLC | $37.54 | 2025 | Magseed |
| Allergan, INC. | $34.80 | 2019 | |
| Sirius Medical Systems | $34.20 | 2024 | Pintuition |
| Teleflex LLC | $24.93 | 2021 | |
| Baxter Healthcare | $24.21 | 2019 | |
| Neotract INC. | $23.59 | 2020 | |
| Molli Surgical (US) INC | $23.18 | 2024 | |
| Medtronic, INC. | $22.91 | 2025 | Emprint |
| Pacira Pharmaceuticals Incorporated | $21.57 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leica Microsystems INC. | $19.07 | 2025 | Mammotome |
| Merck Sharp & Dohme LLC | $18.14 | 2024 | Keytruda |
| Abbott Laboratories | $17.46 | 2019 | |
| Shire North American Group INC | $16.35 | 2019 | |
| Olympus America INC. | $16.19 | 2019 | |
| Covidien LP | $15.41 | 2019 | |
| Kci USA, INC. | $15.00 | 2020 | |
| Reprise Biomedical, INC. | $14.29 | 2025 | Miro3d |
| Mallinckrodt Enterprises LLC | $13.63 | 2019 | |
| Bolder Surgical LLC | $9.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Vela listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.